Condition: Acute Pathology of the Locomotor System · Sponsor: University Hospital, Rouen
The aim of this study is to evaluate whether patients who benefit from a personalized pharmaceutical plan (PPP) during their hospitalization, allowing them to be informed and sensitized, are treated for a shorter period of time with strong opioids with a reduced risk of dependence compared to a management according to the usual modalities in the rheumatology services concerned.
This description comes directly from the study's public registry record.
Catherine CHENAILLER · +3323288 · catherine.chenailler@chu-rouen.fr
Armelle GUIDOTTI · +3323288 · armelle.guidotti@chu-rouen.fr
Always discuss trial participation with your own doctor first.
| CHU de Lille | Lille, France | Recruiting |
| CHU de Nimes | Nîmes, France | Recruiting |
| CHU de ROUEN | Rouen, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05905146